Cargando…
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids
INTRODUCTION: Cystic fibrosis (CF) is a severe monogenic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Several types of CFTR modulators (correctors/potentiators) have been developed to overcome protein dysfunction associated with these mutations...
Autores principales: | Ensinck, Marjolein M., De Keersmaecker, Liesbeth, Ramalho, Anabela S., Cuyx, Senne, Van Biervliet, Stephanie, Dupont, Lieven, Christ, Frauke, Debyser, Zeger, Vermeulen, François, Carlon, Marianne S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016267/ https://www.ncbi.nlm.nih.gov/pubmed/35449760 http://dx.doi.org/10.1183/23120541.00716-2021 |
Ejemplares similares
-
Phenotyping of Rare CFTR Mutations Reveals Distinct Trafficking and Functional Defects
por: Ensinck, Marjolein, et al.
Publicado: (2020) -
Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2023) -
Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
por: Ramalho, Anabela S., et al.
Publicado: (2022) -
One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies
por: Ensinck, Marjolein M., et al.
Publicado: (2022) -
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
por: Maule, Giulia, et al.
Publicado: (2019)